ES482504A1 - Un procedimiento para la preparacion de derivados peptidicos - Google Patents

Un procedimiento para la preparacion de derivados peptidicos

Info

Publication number
ES482504A1
ES482504A1 ES482504A ES482504A ES482504A1 ES 482504 A1 ES482504 A1 ES 482504A1 ES 482504 A ES482504 A ES 482504A ES 482504 A ES482504 A ES 482504A ES 482504 A1 ES482504 A1 ES 482504A1
Authority
ES
Spain
Prior art keywords
group
production
lower alkyl
hydrogen atom
intermediates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES482504A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of ES482504A1 publication Critical patent/ES482504A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0827Tripeptides containing heteroatoms different from O, S, or N
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3808Acyclic saturated acids which can have further substituents on alkyl
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06191Dipeptides containing heteroatoms different from O, S, or N
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/27Cyclic peptide or cyclic protein

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Un procedimiento para la preparación de derivados peptídicos de la fórmula general **(Fórmula)** en donde R10 representa hidrógeno, metilo, mono-, di- , o tri-halometilo, hidroximetilo o hidroximetilo protegido; R20 representa el grupo caracterizante de un alfa-aminoácido del tipo que se encuentra normalmente en las proteínas en donde cualquier grupo amino u otro grupo funcional puede estar en forma protegida o un grupo de alquilo inferior o hidroxi-(alquilo inferior) distinto del grupo caracterizado de un alfa-aminoácido del tipo que se encuentra normalmente en las proteínas; R3 representa un grupo de alquilo inferior, cicloalquilo inferior, alquenilo inferior, arilo o aril-(alquilo inferior); R4 es hidrógeno o alquilo inferior; R5 y R6 representan, cada uno, hidrógeno o un grupo protector de alquilo inferior; R7 es un grupo protector; n tiene un valor de 1, 2 o 3; la configuración en el átomo de carbono designada como (a) es R (cuando R10 = hidrógeno) y la configuración en el átomo de carbono designada como (b). Un procedimiento, caracterizado porque en una forma de realización preferente la suma de l y m en los compuestos reactivos es 2, R3 es alquilo inferior, alquenilo inferior o aril- (alquilo inferior y R4 es hidrógeno).
ES482504A 1977-12-23 1979-07-16 Un procedimiento para la preparacion de derivados peptidicos Expired ES482504A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB5366877 1977-12-23
GB7845272 1978-11-20

Publications (1)

Publication Number Publication Date
ES482504A1 true ES482504A1 (es) 1980-04-01

Family

ID=26267312

Family Applications (2)

Application Number Title Priority Date Filing Date
ES476264A Expired ES476264A1 (es) 1977-12-23 1978-12-22 Un procedimiento para la preparacion de derivados peptidicos
ES482504A Expired ES482504A1 (es) 1977-12-23 1979-07-16 Un procedimiento para la preparacion de derivados peptidicos

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES476264A Expired ES476264A1 (es) 1977-12-23 1978-12-22 Un procedimiento para la preparacion de derivados peptidicos

Country Status (24)

Country Link
US (1) US4250085A (es)
EP (1) EP0002822B1 (es)
JP (1) JPS5492922A (es)
AR (1) AR222479A1 (es)
AT (1) AT365166B (es)
AU (1) AU4258178A (es)
BR (1) BR7808474A (es)
CA (1) CA1108125A (es)
CS (1) CS210680B2 (es)
DE (2) DE2855786A1 (es)
DK (1) DK581178A (es)
ES (2) ES476264A1 (es)
FI (1) FI783959A (es)
FR (3) FR2453866A1 (es)
GR (1) GR72974B (es)
IL (1) IL56241A0 (es)
IT (1) IT1102755B (es)
LU (1) LU80715A1 (es)
MC (1) MC1243A1 (es)
NL (1) NL7812314A (es)
NO (1) NO784354L (es)
NZ (1) NZ189205A (es)
PT (1) PT68978A (es)
SE (1) SE7813274L (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0026867A1 (de) * 1979-09-28 1981-04-15 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Peptidylphosphonsäuren, deren Herstellung und Verwendung und sie enthaltende pharmazeutische Präparate
EP0061172B1 (en) * 1981-03-20 1985-06-19 Kyowa Hakko Kogyo Co., Ltd. Phosphorus-containing oligopeptides, processes for preparation thereof and a pharmaceutical composition containing the same
JPS57156498A (en) * 1981-03-20 1982-09-27 Kyowa Hakko Kogyo Co Ltd Novel physiologically active substance k-26
JPS5831992A (ja) * 1981-08-19 1983-02-24 Kyowa Hakko Kogyo Co Ltd 新規生理活性物質k−4およびその製造法
JPS5885897A (ja) * 1981-11-17 1983-05-23 Kyowa Hakko Kogyo Co Ltd 光学活性な1−アミノ−2−(4−ヒドロキシフエニル)エチルホスホン酸およびその誘導体
EP0103867B1 (en) * 1982-09-17 1986-12-17 Kyowa Hakko Kogyo Co., Ltd. Phosphorus-containing peptide derivative
PT77368A (en) * 1982-09-27 1983-10-01 Lilly Co Eli Improved process for preparing immunomodulating agents or rela-ting there to
US4482488A (en) * 1982-09-27 1984-11-13 Eli Lilly And Company Antibiotic A53868 and process for production thereof
FR2584077B1 (fr) * 1985-06-28 1988-07-08 Irceba L-di ou tripeptides possedant une activite biologique utilisable en medecine humaine et veterinaire, procede pour leur obtention et medicament en contenant
JPH02503440A (ja) * 1988-03-03 1990-10-18 イー・アール・スクイブ・アンド・サンズ・インコーポレイテッド 1,2‐ヒドロキシホスホネートおよびその誘導体
HUT58764A (en) * 1988-07-08 1992-03-30 Smithkline Beckman Corp Process for producing peptides, pharmaceutical compositions containing them and amino-acid intermediates
US5468732A (en) * 1989-02-16 1995-11-21 Pfizer Inc. Phosphorus containing renin inhibitors
WO1990009172A1 (en) * 1989-02-16 1990-08-23 Pfizer Inc. Phosphorus containing renin inhibitors
DE4417478A1 (de) 1994-05-19 1995-11-23 Basf Ag Verfahren zur Herstellung N-Z-geschützter N-methylierter Aminosäuren
US11174288B2 (en) 2016-12-06 2021-11-16 Northeastern University Heparin-binding cationic peptide self-assembling peptide amphiphiles useful against drug-resistant bacteria

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL48835A (en) * 1975-01-27 1979-05-31 Sparamedica Ag Amino acyl and peptidyl derivatives of phophonic acids, their preparation and pharmaceutical compositions containingthem
CA1057082A (en) * 1976-05-13 1979-06-26 Dale K. Bell Air piston differential lockout
JPS6037745Y2 (ja) * 1976-05-18 1985-11-11 富士写真フイルム株式会社 磁気テ−プカセツト
IT1081511B (it) * 1976-07-13 1985-05-21 Hoffmann La Roche Derivati di peptidi e loro preparazione

Also Published As

Publication number Publication date
AT365166B (de) 1981-12-28
LU80715A1 (de) 1980-07-21
FI783959A (fi) 1979-06-24
BR7808474A (pt) 1979-08-21
IL56241A0 (en) 1979-03-12
NZ189205A (en) 1982-03-23
GR72974B (es) 1984-01-20
DK581178A (da) 1979-06-24
CA1108125A (en) 1981-09-01
JPS5492922A (en) 1979-07-23
DE2855786A1 (de) 1979-07-05
FR2453867A1 (fr) 1980-11-07
SE7813274L (sv) 1979-08-08
NO784354L (no) 1979-06-26
CS210680B2 (en) 1982-01-29
NL7812314A (nl) 1979-06-26
ES476264A1 (es) 1980-05-16
US4250085A (en) 1981-02-10
EP0002822B1 (de) 1982-07-28
IT7831276A0 (it) 1978-12-22
FR2446838A1 (fr) 1980-08-14
AR222479A1 (es) 1981-05-29
IT1102755B (it) 1985-10-07
EP0002822A1 (de) 1979-07-11
MC1243A1 (fr) 1979-10-26
DE2861980D1 (en) 1982-09-16
FR2453866A1 (fr) 1980-11-07
ATA918478A (de) 1981-05-15
AU4258178A (en) 1979-06-28
PT68978A (en) 1979-01-01

Similar Documents

Publication Publication Date Title
ES482504A1 (es) Un procedimiento para la preparacion de derivados peptidicos
GR3005315T3 (es)
ES8401466A1 (es) Procedimiento para la obtencion de derivados de piridina.
ES455089A1 (es) Procedimiento de preparacion de nuevas oximas derivadas del acido 7-aminotioazolil-acetamido-cefalosporanico.
ES471822A1 (es) Un procedimiento para la prepracion de derivados del acido n-acilhidroxiaminohidrocarbonfosfonico.
ES8606262A1 (es) Procedimiento para preparar derivados de pleuromutilina
ES8103755A1 (es) Un procedimiento para preparar compuestos de cefem
MY103502A (en) Novel compounds
ES8303397A1 (es) Un procedimiento para la preparacion de nuevos derivados de quinoleinetanol o quinoleinpropanol utiles como medicamentos
ES8103069A1 (es) Procedimiento para la preparacion de derivados de tiazolina
ES8204721A1 (es) Un procedimiento para preparar derivados de halofenil-piri- dilalilamina
ES8205227A1 (es) Procedimiento para la obtencion de derivados del amino-tia- diazolilo
ES8200689A1 (es) Un procedimiento para la produccion de analogos de cefalosporina.
ES8101646A1 (es) Un procedimiento para producir un compuesto opticamente ac- tivo
ES8304125A1 (es) "un procedimiento para la preparacion de nuevos derivados de oxodiazolopirimidina".
ES2018403A6 (es) Procedimiento para preparar nuevas 2-carbonil sustituido-n, n' -di(trimetoxibenzoil) -piperazinas.
ES8401761A1 (es) Un procedimiento para la preparacion de derivados de 1-(3,4,5-trimetoxicinamoil)-4-aminocarboniletil-piperazina sustituidos.
ES8304532A1 (es) "procedimiento de preparacion de derivados de etanolamina".
ES2018404A6 (es) Procedimiento para preparar nuevas 2-metoxicarbonil sustituido-n, n'-di-(trimetoxibenzoil)-piperazinas.
ES8305319A1 (es) "procedimiento para la preparacion de acidos antranilicos sustituidos con radicales basicos"
FR2361896A1 (fr) Nouveaux derives de la cephalosporine, leur procede de preparation et leur application comme medicament
ES8203328A1 (es) Un procedimiento para la preparacion de 6-fluordihidroxifenilalaninas.
ES8103774A1 (es) Un procedimiento para preparar nuevos compuestos de triazeno